20th Canadian Melanoma Conference 2026 - Saturday, February 28, 2026

Programs and Speakers

By proceeding, you agree that OncologyEducation may anonymize any provided information, and use it for marketing research and/or promotional purposes.

Question Title

1. Occupation (please check one):

Physician (Internal Medicine)

Medical Oncologist

Radiation Oncologist

Surgeon

Surgical Oncologist

Nurse

Pharmacist

Resident / Fellow

Industry / Pharmaceutical Company

Dermatologist

Other (please specify)

Question Title

2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 3, that you found impactful and would like more detailed information.

Question Title

3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.

	Excellent	Very Good	Good	Fair	Poor
Address from Melanoma Canada - Falyn Katz	Address from Melanoma Canada - Falyn Katz Excellent	Address from Melanoma Canada - Falyn Katz Very Good	Address from Melanoma Canada - Falyn Katz Good	Address from Melanoma Canada - Falyn Katz Fair	Address from Melanoma Canada - Falyn Katz Poor
Skin Cancer in Patients of Colour - Dr. Harvey Lui	Skin Cancer in Patients of Colour - Dr. Harvey Lui Excellent	Skin Cancer in Patients of Colour - Dr. Harvey Lui Very Good	Skin Cancer in Patients of Colour - Dr. Harvey Lui Good	Skin Cancer in Patients of Colour - Dr. Harvey Lui Fair	Skin Cancer in Patients of Colour - Dr. Harvey Lui Poor
Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau	Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau Excellent	Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau Very Good	Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau Good	Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau Fair	Margins, Management, and Medical Alternatives: The Grey Zones in Nevi and Lentigo Maligna - Dr. Maxwell Sauder & Dr Joël Claveau Poor
Margins & Satellites - Dr. Vernon Sondak	Margins & Satellites - Dr. Vernon Sondak Excellent	Margins & Satellites - Dr. Vernon Sondak Very Good	Margins & Satellites - Dr. Vernon Sondak Good	Margins & Satellites - Dr. Vernon Sondak Fair	Margins & Satellites - Dr. Vernon Sondak Poor
Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi	Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi Excellent	Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi Very Good	Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi Good	Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi Fair	Surgery in Advanced Stage 4 Melanoma - Prof. Alexander van Akkooi Poor
Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi	Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi Excellent	Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi Very Good	Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi Good	Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi Fair	Surgical & Dermatology Panel Discussion and Q&A - Dr. Harvey Lui, Dr. Vernon Sondak and Prof. Alexander van Akkooi Poor
Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi	Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi Excellent	Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi Very Good	Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi Good	Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi Fair	Systemic Therapy for Brain Metastases in Melanoma - Prof. Hussein Tawbi Poor
Radiation - Dr. Tina Zhang	Radiation - Dr. Tina Zhang Excellent	Radiation - Dr. Tina Zhang Very Good	Radiation - Dr. Tina Zhang Good	Radiation - Dr. Tina Zhang Fair	Radiation - Dr. Tina Zhang Poor
Canadian Guidelines - Dr. Teresa Petrella	Canadian Guidelines - Dr. Teresa Petrella Excellent	Canadian Guidelines - Dr. Teresa Petrella Very Good	Canadian Guidelines - Dr. Teresa Petrella Good	Canadian Guidelines - Dr. Teresa Petrella Fair	Canadian Guidelines - Dr. Teresa Petrella Poor
Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang	Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang Excellent	Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang Very Good	Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang Good	Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang Fair	Managing CNS Metastases Panel Discussion and Q&A - Dr. Teresa Petrella, Prof. Hussein Tawbi and Dr. Tina Zhang Poor

Question Title

4. Please indicate your level of agreement with the following:

	Strongly Agree	Agree	Neutral	Disagree	Strongly disagree
Content was based on best available scientific evidence	Content was based on best available scientific evidence Strongly Agree	Content was based on best available scientific evidence Agree	Content was based on best available scientific evidence Neutral	Content was based on best available scientific evidence Disagree	Content was based on best available scientific evidence Strongly disagree
Programs were free from commercial influence or bias	Programs were free from commercial influence or bias Strongly Agree	Programs were free from commercial influence or bias Agree	Programs were free from commercial influence or bias Neutral	Programs were free from commercial influence or bias Disagree	Programs were free from commercial influence or bias Strongly disagree
Information was presented in an objective and educationally balanced manner	Information was presented in an objective and educationally balanced manner Strongly Agree	Information was presented in an objective and educationally balanced manner Agree	Information was presented in an objective and educationally balanced manner Neutral	Information was presented in an objective and educationally balanced manner Disagree	Information was presented in an objective and educationally balanced manner Strongly disagree
Sufficient time was allowed for Q&A	Sufficient time was allowed for Q&A Strongly Agree	Sufficient time was allowed for Q&A Agree	Sufficient time was allowed for Q&A Neutral	Sufficient time was allowed for Q&A Disagree	Sufficient time was allowed for Q&A Strongly disagree
The abstracts presented were interesting and relevant to me	The abstracts presented were interesting and relevant to me Strongly Agree	The abstracts presented were interesting and relevant to me Agree	The abstracts presented were interesting and relevant to me Neutral	The abstracts presented were interesting and relevant to me Disagree	The abstracts presented were interesting and relevant to me Strongly disagree
Speakers were of high quality	Speakers were of high quality Strongly Agree	Speakers were of high quality Agree	Speakers were of high quality Neutral	Speakers were of high quality Disagree	Speakers were of high quality Strongly disagree
I gained new insight and knowledge that will be of benefit to me	I gained new insight and knowledge that will be of benefit to me Strongly Agree	I gained new insight and knowledge that will be of benefit to me Agree	I gained new insight and knowledge that will be of benefit to me Neutral	I gained new insight and knowledge that will be of benefit to me Disagree	I gained new insight and knowledge that will be of benefit to me Strongly disagree
Based on the information presented, I plan to make changes to my work	Based on the information presented, I plan to make changes to my work Strongly Agree	Based on the information presented, I plan to make changes to my work Agree	Based on the information presented, I plan to make changes to my work Neutral	Based on the information presented, I plan to make changes to my work Disagree	Based on the information presented, I plan to make changes to my work Strongly disagree
Overall, the quality of the meeting was of a high standard	Overall, the quality of the meeting was of a high standard Strongly Agree	Overall, the quality of the meeting was of a high standard Agree	Overall, the quality of the meeting was of a high standard Neutral	Overall, the quality of the meeting was of a high standard Disagree	Overall, the quality of the meeting was of a high standard Strongly disagree
I will attend this meeting again next year	I will attend this meeting again next year Strongly Agree	I will attend this meeting again next year Agree	I will attend this meeting again next year Neutral	I will attend this meeting again next year Disagree	I will attend this meeting again next year Strongly disagree
I will recommend upcoming OncologyEducation events to my colleagues	I will recommend upcoming OncologyEducation events to my colleagues Strongly Agree	I will recommend upcoming OncologyEducation events to my colleagues Agree	I will recommend upcoming OncologyEducation events to my colleagues Neutral	I will recommend upcoming OncologyEducation events to my colleagues Disagree	I will recommend upcoming OncologyEducation events to my colleagues Strongly disagree

Question Title

* 1. Occupation (please check one):

Question Title

* 2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 3, that you found impactful and would like more detailed information.

Question Title

* 3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.

Question Title

* 4. Please indicate your level of agreement with the following:

1. Occupation (please check one):

2. Please provide the authors names and titles of any CLINICAL TRIALS presented today, CMC 2026 Day 3, that you found impactful and would like more detailed information.

3. Please rate the sessions as follows in regards to their relevance to you or how it will change your practice.

4. Please indicate your level of agreement with the following: